论文部分内容阅读
静脉注射免疫球蛋白(IVIG)作为重要的免疫治疗制剂,已广泛应用于多种免疫相关性疾病的治疗。近年来,国内实验研究表明,免疫系统及其功能异常可能参与了新生儿缺氧缺血性脑病(HIE)的发病,使临床利用免疫疗法治疗HIE已成为可能。现将IVIG治疗HIE的观察结果报告如下。
Intravenous immunoglobulin (IVIG), as an important immunotherapeutic agent, has been widely used in the treatment of a variety of immune-related diseases. In recent years, the domestic experimental studies have shown that the immune system and its dysfunction may be involved in the pathogenesis of neonatal hypoxic-ischemic encephalopathy (HIE), the clinical use of immunotherapy for HIE has become possible. Now the results of IVIG treatment of HIE are reported below.